{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"164-861-015-052-72X","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"164-861-015-052-72X","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":10811,"type":"PATENT","title":"Rice University - Patent Portfolio","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":3645,"tags":[],"user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"notes":[{"id":8274,"type":"COLLECTION","user":{"id":91044780,"username":"Cambialens","firstName":"","lastName":"","created":"2015-05-04T00:55:26.000Z","displayName":"Cambialens","preferences":"{\"usage\":\"public\",\"beta\":false}","accountType":"PERSONAL","isOauthOnly":false},"text":"
Search Applicants and Owners separately: \"Rice Univ*\"
Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 2561
Search Applicants and Owners separately: \"Rice Univ*\"
Select more for logical variants. Add to collection. Select all patents in the collection and expand by simple families. Add to collection. Total patents: 2561
a divalent cation in an amount sufficient to promote healing of the skin injury or laceration in conjunction with the SAP-binding agarose in a concentration sufficient to promote healing of the skin injury or laceration more quickly than the SAP-binding agarose alone."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 1, further comprising an additional wound healing factor."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 2, wherein the additional wound healing factor is selected from the group consisting of: interleukin (IL)-4, IL-13, fibroblast growth factor (FGF), transforming growth factor beta (TGFβ), and any combinations thereof."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 1, further comprising IL-13 at a concentration of 0.1 to 10 ng/ml."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 1, further comprising IL-4 at a concentration of 0.1 to 10 ng/ml."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 1, further comprising a bandage."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 1, wherein the divalent cation is Ca2+."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["A wound dressing comprising:\n
a Serum Amyloid P (SAP)-binding high electroendosmosis (EEO) agarose, the SAP-binding agarose operable to promote healing of a skin injury or laceration in a mammal; and\n
a divalent cation in an amount sufficient to promote healing of the skin injury or laceration in conjunction with the SAP-binding agarose in a concentration sufficient to promote healing of the skin injury or laceration more quickly than the SAP-binding agarose alone."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 8, wherein the divalent cation is Ca2+."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 9, further comprising approximately 1% (w/v) high EEO agarose."],"number":10,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 8, further comprising an additional wound healing factor."],"number":11,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 11, wherein the additional wound healing factor is selected from the group consisting of: interleukin (IL)-4, IL-13, fibroblast growth factor (FGF), transforming growth factor beta (TGFβ), and any combinations thereof."],"number":12,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 12, further comprising IL-13 at a concentration of 0.1 to 10 ng/ml."],"number":13,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of 12, further comprising IL-4 at a concentration of 0.1 to 10 ng/ml."],"number":14,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 8, further comprising a bandage."],"number":15,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 8, wherein the SAP-binding high EEO agarose comprises a pyruvate acetal of galactose."],"number":16,"annotation":false,"claim":true,"title":false},{"lines":["A wound dressing comprising:\n
a Serum Amyloid P (SAP)-binding agarose comprising a phosphoethanolamine moiety, the SAP-binding agarose operable to promote healing of a skin injury or laceration in a mammal; and\n
a divalent cation in an amount sufficient to promote healing of the skin injury or laceration in conjunction with the SAP-binding agarose in a concentration sufficient to promote healing of the skin injury or laceration more quickly than the SAP-binding agarose alone."],"number":17,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 17, wherein the divalent cation is Ca2+."],"number":18,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 17, further comprising an additional wound healing factor."],"number":19,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 19, wherein the additional wound healing factor is selected from the group consisting of: interleukin (IL)-4, IL-13, fibroblast growth factor (FGF), transforming growth factor beta (TGFβ), and any combinations thereof."],"number":20,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 17, further comprising IL-13 at a concentration of 0.1 to 10 ng/ml."],"number":21,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 17, further comprising IL-4 at a concentration of 0.1 to 10 ng/ml."],"number":22,"annotation":false,"claim":true,"title":false},{"lines":["The wound dressing of claim 17, further comprising a bandage."],"number":23,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}